Literature DB >> 30955514

Lung Cancer.

Faria Nasim1, Bruce F Sabath1, George A Eapen2.   

Abstract

Lung cancer is the world's leading cause of cancer death. Screening for lung cancer by low-dose computed tomography improves mortality. Various modalities exist for diagnosis and staging. Treatment is determined by subtype and stage of cancer; there are several personalized therapies that did not exist just a few years ago. Caring for the patient with lung cancer is a complex task. This review provides a broad outline of this disease, helping clinicians identify such patients and familiarizing them with lung cancer care options, so they are better equipped to guide their patients along this challenging journey.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Lung cancer; Screening; Smoking; Staging

Mesh:

Year:  2019        PMID: 30955514     DOI: 10.1016/j.mcna.2018.12.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  170 in total

1.  Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis.

Authors:  Lizhong Zeng; Xin Lyu; Jingyan Yuan; Wei Wang; Nannan Zhao; Boxuan Liu; Ruiying Sun; Xia Meng; Shuanying Yang
Journal:  Am J Transl Res       Date:  2020-08-15       Impact factor: 4.060

2.  Altered miR-93-5p/miR-18a expression in serum for diagnosing non-small cell lung cancer.

Authors:  Lili Shao; Xiaomin Lu; Yan Zhou; Yan Wang; Xiaoli Wang; Zhixiang Zhuang; Jun Gong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  22-O-(N-Boc-L-glycine) ester of renieramycin M inhibits migratory activity and suppresses epithelial-mesenchymal transition in human lung cancer cells.

Authors:  Yamin Oo; Justin Quiel Lasam Nealiga; Khanit Suwanborirux; Supakarn Chamni; Gea Abigail Uy Ecoy; Varisa Pongrakhananon; Pithi Chanvorachote; Chatchai Chaotham
Journal:  J Nat Med       Date:  2021-07-21       Impact factor: 2.343

4.  Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer.

Authors:  Zafer Bayraktutan; Ahmet Kiziltunc; Ebubekir Bakan; Hamit Hakan Alp
Journal:  Eurasian J Med       Date:  2020-06-05

5.  MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function.

Authors:  Nianqing Wan; Jianxiao Zheng
Journal:  Oncol Lett       Date:  2021-05-02       Impact factor: 2.967

6.  Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells.

Authors:  Xu-Ge Wei; Ke-Wei Bi; Bo Li
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

7.  GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling.

Authors:  Fan Zhang; Jingfei Meng; Hong Jiang; Xing Feng; Dongshan Wei; Wen Meng
Journal:  Anal Cell Pathol (Amst)       Date:  2021-05-01       Impact factor: 2.916

8.  miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.

Authors:  Sangsang Chen; Xuqing Zhu; Jing Zheng; Tingting Xu; Yinmin Xu; Feng Chen
Journal:  Comput Math Methods Med       Date:  2021-07-07       Impact factor: 2.238

9.  The effect of the enhanced recovery after surgery program on lung cancer surgery: a systematic review and meta-analysis.

Authors:  Rongyang Li; Kun Wang; Chenghao Qu; Weifeng Qi; Tao Fang; Weiming Yue; Hui Tian
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

10.  Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer.

Authors:  Boyang Liu; Ruiping Zhang; Yungang Zhu; Ruisheng Hao
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.